ʻAʻole hiki i ka COVID-19 ke kumu wale i nā hoʻopiʻi koʻikoʻi i ka maʻi diabetes type 2, akā kōkua pū kekahi i ka hoʻomohala ʻana o ka maʻi maʻi i nā poʻe olakino ma mua, e hōʻike ana i kahi hui honua o nā ʻepekema i ka New England Journal of Medicine.
- Ma waena o nā mea maʻi i make mai COVID-19, 20 a 30 pakeneka. he maʻi diabetes ma mua. ʻO ka maʻi maʻi mellitus kekahi o nā mea maʻamau i kapa ʻia he comorbidities
- ʻO ka maʻi maʻi maʻi i loko o kahi mea maʻi i loaʻa i ka coronavirus hou e pili ana me ka pilikia nui o ka COVID-19 koʻikoʻi a me ka make mai ia mea.
- Ma ka ʻaoʻao ʻē aʻe, ua ʻike ʻia nā hihia hou o ka maʻi diabetes i nā mea maʻi me COVID-19. ʻAʻole hiki i nā kānaka ʻepekema ke wehewehe i kēia ʻano
I mea e hoʻomaopopo maikaʻi ai i ka pilina ma waena o COVID-19 a me ka maʻi diabetes, ua hoʻokumu kahi hui honua o nā mea noiʻi diabetology alakaʻi ma ka papahana CoviDIAB i kahi papa inoa honua o nā maʻi i hoʻomohala i ka maʻi diabetes ma hope o ka hoʻomohala ʻana i ka COVID-19.
Loaʻa kēia i ke kōkua e hoʻomaopopo maikaʻi i ka nui o ka hanana, wehewehe i nā hōʻailona o ka hoʻomohala ʻana i ka maʻi maʻi i nā maʻi me COVID-19 a me nā ala kūpono loa o kāna mālama ʻana a me ka nānā ʻana i ke kūlana o nā maʻi. E kōkua nō hoʻi ia e pane i ka nīnau no ka hala ʻana o ka haʻalulu glucose metabolism i ka manawa ma hope o ka hoʻōla ʻana o ka maʻi.
Ke hoʻomanaʻo nei ka poʻe noiʻi ma ka New England Journal of Medicine, ʻo nā ʻike i kēia manawa e hōʻike ana i ke ola o kahi pilina ʻelua ma waena o COVID-19 a me ka maʻi diabetes. Ma ka ʻaoʻao hoʻokahi, ʻo ka hele ʻana o ka maʻi maʻi i ka mea maʻi i loaʻa i ka maʻi coronavirus hou e pili ana me kahi kiʻekiʻe o ka nui o ka COVID-19 a me ka make mai ia mea. Ma waena o nā mea maʻi i make mai COVID-19, 20 a 30 pakeneka. he maʻi diabetes ma mua. Loaʻa i kēia mau maʻi nā hoʻopiʻi metabolic atypical o ka maʻi diabetes mellitus, me ka ketoacidosis hoʻoweliweli a me ka hyperosmolarity plasma. Ma ka ʻaoʻao ʻē aʻe, ua ʻike ʻia nā hihia hou o ka maʻi diabetes i nā mea maʻi me COVID-19.
ʻAʻole i ʻike maopopo ʻia pehea ka hopena o ka maʻi SARS-Cov-2 e hoʻokau nei i ka COVID-19 i ka hoʻomohala ʻana o ka maʻi maʻi, ua ʻōlelo ka poʻe noiʻi. Ua hōʻike ʻia nā haʻawina mua ʻo ka protein ACE2, kahi e komo ai ka maʻi i loko o nā cell, ʻaʻole wale ma luna o nā ʻōpū māmā, akā ma nā ʻāpana nui a me nā ʻiʻo ʻē aʻe e pili ana i nā kaʻina metabolic, e like me ka pancreas, ate, nā puʻupaʻa, nā ʻōpū liʻiliʻi, nā kiko. momona. Manaʻo ka poʻe noiʻi ma ka hoʻopili ʻana i kēia mau ʻiʻo, ke kumu o ka maʻi i nā maʻi paʻakikī a paʻakikī o ka metabolism glucose, ʻaʻole hiki ke hāʻawi wale i nā hoʻopiʻi i nā poʻe i loaʻa i ka maʻi diabetes, akā i ka ulu ʻana o kēia maʻi i nā maʻi i loaʻa ʻole kahi maʻi. o ka maʻi diabetes.
"Ma muli o ka pōkole o ka hoʻolaha ʻana o ke kanaka i ka coronavirus hou a hiki i kēia lā, ʻaʻole maopopo ka ʻano o ka maʻi e hoʻopilikia ai i ka metabolism glucose. ʻAʻole mākou i ʻike inā ʻo nā hōʻailona koʻikoʻi o ka maʻi maʻi i kēia mau maʻi he ʻano 1, ʻano 2 a i ʻole he ʻano hou o ka maʻi diabetes "- i ʻōlelo ai ka mea kākau kumu o ka ʻike ma" NEJM "prof. ʻO Francesco Rubino o King's College London a me kekahi o nā mea noiʻi ma hope o ka papahana hoʻopaʻa inoa CoviDiab.
ʻO kekahi kanaka diabetologist i komo i ka papahana, prof. ʻO Paul Zimmet o ke Kulanui ʻo Monash ma Melbourne i koʻikoʻi i kēia manawa ʻaʻole ʻike ʻia ka maʻi maʻi maʻi i hoʻokumu ʻia e COVID-19; ʻAʻole ʻike ʻia inā e hoʻomau a hoʻoholo paha ka maʻi maʻi ma hope o ka hoʻōla ʻana o ka maʻi. "Ma ka hana ʻana i kahi papa inoa honua, kāhea mākou i ke kaiāulu olakino honua e kaʻana wikiwiki i nā ʻike lapaʻau e kōkua i ka pane ʻana i kēia mau nīnau" - hoʻopau ka loea.
Loaa aku oi:
- ʻEhia pole i loaʻa i ka maʻi diabetes? He ahulau
- I kēlā me kēia 10 kekona make kekahi ma muli o ia. Piʻi ka pilikia me ka makahiki a me ke kaumaha
- ʻAʻole wale ka momona. He aha ka mea e pilikia ai mākou i ka maʻi diabetes?